elevated serum uric acid levels are associated with gouty arthritis
also elevated uric acid levels have been reported to increase the risk of cardiovascular disease (CVD)
elevated serum uric acid levels were shown to increase the risk of CVD in prospective cohort studies concerning high-risk groups such as patients with gout, hypertension, stroke, congestive heart failure (CHF) , and/or diabetes
the First National Health and Nutrition Examination Survey (NHANES-I) found an independent relationship between elevated serum uric acid levels and CVD-related mortality that demonstrated a higher relative risk (RR) in women than in men (RR 1.30 versus 1.17) (1)
a prospective cohort study of 41,879 men and 48,514 women ages 35 years was conducted using data from the MJ Health Screening Centers in Taiwan (2)
mortality from all causes, total cardiovascular disease (CVD), ischemic stroke, congestive heart failure, hypertensive disease, and coronary heart disease were compared according to increasing serum uric acid levels
a total of 1,151 (21.2%) events of 5,427 total deaths were ascribed to CVD (mean followup 8.2 years). Hazard ratios (HRs) for hyperuricemia (serum uric acid level >7 mg/dl (>420 µmoles/litre) were estimated with Cox regression model after adjusting for age, sex, body mass index, cholesterol, triglycerides, diabetes, hypertension, heavy cigarette smoking, and frequent alcohol consumption
in all patients, HRs were 1.16 (P < 0.001) for all-cause mortality, 1.39 (P < 0.001) for total CVD, and 1.35 (P = 0.02) for ischemic stroke
in subgroup analysis, the HRs for cardiovascular risk remained significant in patients with hypertension (1.44, P < 0.001) and in patients with diabetes (1.64, P < 0.001)
in a low metabolic risk subgroup, the HRs for all-cause mortality and total cardiovascular morbidity were 1.24 (P = 0.02) and 1.48 (P = 0.16), respectively
the study authors concluded that hyperuricemia was an independent risk factor of mortality from all causes, total CVD, and ischemic stroke in the Taiwanese general population, in high-risk groups, and potentially in low-risk groups
Reference:
1) Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic followup study. Am J Epidemiol 1995; 141: 637-44
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.